Cartalax Peptide

Short bioregulatory tripeptide (Ala-Glu-Asp) from cartilage extract. Khavinson peptide researched for chondroprotective and anti-aging effects on connective tissue.

Coming Soon

This compound is currently in our development pipeline. Enter your email to be notified when it becomes available for research purchase.

Quick Facts

SKUCART-001
SequenceAla-Glu-Asp
Purity≥98%
Physical FormLyophilized Powder
StorageStore at -20°C

What is Cartalax (Ala-Glu-Asp)?

Khavinson tripeptide from cartilage extract. Researched for chondroprotective effects, normalizing cartilage metabolism and inhibiting matrix metalloproteinase-mediated collagen degradation in joints.

Frequently Asked Questions

What conditions is Cartalax researched for?

Cartalax is studied for osteoarthritis, age-related cartilage degradation, and joint inflammation models. It acts at the gene expression level to normalize chondrocyte function and matrix turnover.

For laboratory and research use only. Not intended for human or animal consumption. All product information is derived from published preclinical research and does not constitute medical advice or claims.